# A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

> **NCT01203072** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 523 (actual)

## Conditions studied

- Venous Thromboembolism
- Deep Vein Thrombosis
- Total Knee Arthroplasty

## Interventions

- **DRUG:** DU-176b
- **DRUG:** DU-176b
- **DRUG:** DU-176b
- **DRUG:** DU-176b
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01203072
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-09
- **Final completion:** 2008-07
- **Target enrollment:** 523 (ACTUAL)
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01203072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01203072, "A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01203072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*